Each year the Radboud university medical center in Nijmegen awards the so called "Radboudpluim" award to colleagues who have delivered extraordinary performances aligned with the Radboudumc goals and values.This year Marion Hermans, nurse practitioner at the RCMM, was awared the Radboudpluim. Radboudumc board member Cathy van Beek and RCMM chair Jan Smeitink praised her valuable contribution to patient-centered care and increasing disease awareness in the general public. For example, Marion optimises child care in the field of mitochondrial disorders, organises the annual patient information day, organises events during the global mitochondrial disease awareness week and is pro-active in developing information about mitochondrial disorders for patients and the general public.
We congratulate Marion with this much deserved distinction!
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Sonlicromanol seems promising for certain cancers Khondrion announces publication in PLOS ONE of new research13 July 2021
Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol’s active metabolite.read more
Newborn screening in sight through the discovery of novel disease biomarkers by new technique8 July 2021
To identify new biomarkers that can be used in the newborn screening protocol, also known as the neonatal heel prick, Karlien Coene and colleagues joined forces with scientists at the Radboud University’s FELIX laser laboratory. They published their findings in The Journal of Clinical Investigation.read more
Biomarkers for pyridoxine-dependent epilepsy identified by untargeted metabolomics and infrared ion spectroscopy24 June 2021
Karlien Coene, theme Metabolic Diseases, and colleagues published in the Journal of Clinical Investigation that untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy.read more
Miniaturized microfluidic platform for automated epigenetic profiling6 May 2021
Together with Fluidigm, a US-based company focusing on microfluidics, the team of Hendrik Marks publishes in Genome Research the development of a powerful plug and play ChIP-seq platform for minute amount of cells, such as embryonic specimens or small biopsies.read more
Medication for the body's malfunctioning energy system in the works28 April 2021
Radboudumc’s spin-off company Khondrion is developing the promising drug sonlicromanol for treating energy metabolism diseases. Founder of the company Jan Smeitink, theme metabolic disorders, explains.read more
Clara van Karnebeek receives a European grant for CHARLIE project28 April 2021
Clara van Karnebeek has received a European grant of 1.88 million Euros for the CHARLIE consortium: an international collaboration to use genetic and stem cell technology to develop new treatments for the neurometabolic diseases GA1 and PDE.read more